Cargando…
Retraction: DMA, a Bisbenzimidazole, Offers Radioprotection by Promoting NFκB Transactivation through NIK/IKK in Human Glioma Cells
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7269245/ https://www.ncbi.nlm.nih.gov/pubmed/32492047 http://dx.doi.org/10.1371/journal.pone.0234365 |
Ejemplares similares
-
DMA, a Bisbenzimidazole, Offers Radioprotection by Promoting NFκB Transactivation through NIK/IKK in Human Glioma Cells
por: Kaur, Navrinder, et al.
Publicado: (2012) -
Retracted: KL-FGF23-VD Axis in Improving Late-Onset Alzheimer's Disease by Modulating IKK/NF-κB Signal Pathway
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023) -
Retraction: Plumbagin Suppresses the Invasion of HER2-Overexpressing Breast Cancer Cells through Inhibition of IKKα-Mediated NF-κB Activation
Publicado: (2019) -
Inhibitory-κB Kinase (IKK) α and Nuclear Factor-κB (NFκB)-Inducing Kinase (NIK) as Anti-Cancer Drug Targets
por: Paul, Andrew, et al.
Publicado: (2018) -
Retraction: PATZ1 induces PP4R2 to form a negative feedback loop on IKK/NF-κB signaling in lung cancer
Retraction: MIG-7 and phosphorylated prohibitin coordinately regulate lung cancer invasion/metastasis
por: Ho, Ming-Yi, et al.
Publicado: (2019)